CN Menu
Focus on Unmet Clinical Needs and Achieve Medical Value
View More
See More
About Evergreen
Our Vision: To Become One of the Most Dynamic and Innovative Pharmaceutical Enterprise in China

Evergreen Therapeutics is a fast-growing international pharmaceutical company with the mission to "focus on unmet clinical needs and achieve medical value". Evergreen's scientists are using artificial intelligence (AI) to speed up pharmaceutical product development and commercialization worldwide.

Evergreen has 13 product pipelines and 80 patent cases, of which 15 patent applications have been granted covering major global pharmaceutical markets, including China, United States, Europe, Japan and others. The development of four orphan drug pipelines, currently with no officially approved products, will provide access to treatment for patients with rare diseases, while also generate significant social and economic benefits.

With a focus on the development of innovative drugs in the fields of autoimmunity, tumor immunity, and chronic diseases, Evergreen adheres to a strategy of globalization and differentiation via actively carrying out development of new indications for existing drugs while exploring new targets. Keeping an open mind, Evergreen not only vigorously promotes independent research and development, but also promotes and seeks strategic cooperations and opportunities worldwide. It utilizes first-class technology to develop high-quality products to meet the urgent clinical needs of patients and realize enterprise value for our investors.

View More
Product Pipeline
R&D and Product Pipeline
Evergreen is simultaneously developing drug candidates for 13 clinical indications; development of these products began in 2013, with the INDs for three clinical conditions officially granted by the FDA between late September and late October 2020.
View More
Latest News
Learn More About Evergreen
Evergreen is a fast-growing international biomedical company with the mission of "focus on clinical needs, achieve medical value". Evergreen is committed to clinical R&D and commercialization worldwide.
View More